CCND1 and cancer: In addition, vitamin K2 can reduce cyclin D1 expression in cancer cells by inhibiting the binding of the nuclear factor κB (NF-κB) to the cyclin D1 promoter, which occurs by arresting the cell cycle in the G1 phase [23].